Objective: To compare caregiver-reported preventive medication use and pharmacy data with medications available at home for children with persistent asthma, and identify factors associated with having preventive medication at home.
Methods:We analyzed baseline data from the School-Based Telemedicine Enhanced Asthma Management (SB-TEAM) study, including medication use, symptoms, and demographics. Research assistants documented all asthma medications available during home visits. We reviewed pharmacy records for a subset of children. Bivariate and multivariate analyses identified factors associated with having any preventive medication in the home.
Results:We included 335 children (mean 7.7yrs, 56% Black, 34% Hispanic, 77% Medicaid; participation 79%). Most caregivers (69%) reported preventive medication use, yet only 45% had preventive medication at home. Compared to families with preventive medication at home, more families without preventive medication reported discontinuous insurance in the prior year (7% v 15%, p=0.02) and medication sharing (22% v 32%, p=0.04). For the subset with pharmacy records (n=192), 40% filled a preventive medication in the past year and 15% had a preventive medication at home. In multivariate analyses, children were less likely to have preventive medication at home when caregivers reported no preventive medication use in the past 2 weeks (OR 0.25; 95%CI 0.14,0.43), discontinuous insurance (OR 0.42; 95%CI 0.19,0.97), medication sharing (OR 0.54; 95%CI 0.32,0.91), or caregiver education ≥HS (OR 0.59; 95%CI 0.35,0.99).
Conclusion:Among urban children with persistent asthma, neither caregiver-report nor pharmacy data reflect home preventive medication availability. Inquiring about insurance coverage and medication sharing may improve preventive medication availability for these children.